Tomasovic, A., Brand, T., Schanbacher, C., Kramer, S., Hümmert, M. W., Godoy, P., . . . Lorenz, K. (2020). Interference with ERK-dimerization at the nucleocytosolic interface targets pathological ERK1/2 signaling without cardiotoxic side-effects. Nature Portfolio.
Chicago Style (17th ed.) CitationTomasovic, Angela, et al. Interference with ERK-dimerization at the Nucleocytosolic Interface Targets Pathological ERK1/2 Signaling Without Cardiotoxic Side-effects. Nature Portfolio, 2020.
MLA (8th ed.) CitationTomasovic, Angela, et al. Interference with ERK-dimerization at the Nucleocytosolic Interface Targets Pathological ERK1/2 Signaling Without Cardiotoxic Side-effects. Nature Portfolio, 2020.
Warning: These citations may not always be 100% accurate.